Literature DB >> 21592062

From treatment adherence to advanced shared decision making: new professional strategies and attitudes in mental health care.

Giuseppe Tibaldi1, Luis Salvador-Carulla, Juan Carlos García-Gutierrez.   

Abstract

Treatment adherence is related to "self-regulation" of prescribed drugs. Patients organise their drug intake around their own priorities, which may be very different from prescribers' priorities, since most of the patients value their personal concerns and/or their social roles more than the benefits of a prescribed treatment. A gap exists between patients' and professionals' views. This gap is mainly related to patients' health beliefs and physicians' attitudes. A number of strategies can help professionals overcome gaps between their treatment options for depression and schizophrenia and the "real world" alternatives shared by the lay public, patients, their relatives, and political stakeholders. These strategies include integrated care and recovery, family engagement, and the development of a mutualistic patient/physician relationship with the adoption of advance directives and appropriate guidelines that incorporate the patient's choices. The effective implementation of these combined strategies within the person-centred care model empowers patients to collaborate with mental health professionals and their families in making complex health care choices. Barriers to this process include factors affecting the control, contact and communication facets of the patient/physician relationship.

Entities:  

Mesh:

Year:  2011        PMID: 21592062     DOI: 10.2174/157488411796151101

Source DB:  PubMed          Journal:  Curr Clin Pharmacol        ISSN: 1574-8847


  9 in total

1.  Background, Structure and Priorities of the 2013 Geneva Declaration on Person-centered Health Research.

Authors:  Luis Salvador-Carulla; C Robert Cloninger; Amalia Thornicroft; Juan E Mezzich
Journal:  Int J Pers Cent Med       Date:  2013

2.  The development of the DSM-5 Cultural Formulation Interview-Fidelity Instrument (CFI-FI): a pilot study.

Authors:  Neil Krishan Aggarwal; Andrew Glass; Amilcar Tirado; Marit Boiler; Andel Nicasio; Margarita Alegría; Melanie Wall; Roberto Lewis-Fernández
Journal:  J Health Care Poor Underserved       Date:  2014-08

3.  Contributions of community pharmacists to patients on antidepressants-a qualitative study among key informants.

Authors:  Laurence Guillaumie; Jocelyne Moisan; Jean-Pierre Grégoire; Denis Villeneuve; Clément Beaucage; Lilianne Bordeleau; Sophie Lauzier
Journal:  Int J Clin Pharm       Date:  2017-06-26

Review 4.  [Treat-to-target from the perspective of office-based rheumatology].

Authors:  K Krüger; K Karberg
Journal:  Z Rheumatol       Date:  2011-10       Impact factor: 1.372

5.  End-of-Life Decisions in Albania: The Call for an Ethical Revision.

Authors:  Denard Veshi; Ervin Pupe; Carlo Venditti; Ilir Kalemaj; Enkelejda Koka; Michele Biring-Pani; Hektor Ruci
Journal:  Liverp Law Rev       Date:  2020-06-24

6.  The capacity of schizophrenia and bipolar disorder individuals to make autonomous decisions about pharmacological treatments for their illness in real life: A scoping review.

Authors:  Enric Vincens Pons; Luis Salvador-Carulla; Alfredo Calcedo-Barba; Silvia Paz; Thomas Messer; Bruno Paccardi; Scott L Zeller
Journal:  Health Sci Rep       Date:  2020-08-09

7.  The relationship of psychological reactance, health locus of control and sense of self-efficacy with adherence to treatment in psychiatric outpatients with depression.

Authors:  Carlos De Las Cuevas; Wenceslao Peñate; Emilio J Sanz
Journal:  BMC Psychiatry       Date:  2014-11-21       Impact factor: 3.630

Review 8.  Treatment-adherence in bipolar disorder: A patient-centred approach.

Authors:  Subho Chakrabarti
Journal:  World J Psychiatry       Date:  2016-12-22

Review 9.  Factors influencing the outcome of integrated therapy approach in schizophrenia: A narrative review of the literature.

Authors:  Giulia M Giordano; Francesco Brando; Pasquale Pezzella; Maria De Angelis; Armida Mucci; Silvana Galderisi
Journal:  Front Psychiatry       Date:  2022-08-30       Impact factor: 5.435

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.